Maryland State Retirement & Pension System’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
ACG
GCM
SIAU
AIM
Maryland State Retirement & Pension System's DNA Position: Q2 2024 in Review
Maryland State Retirement & Pension System sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 3,033 shares — an estimated $107K sold.
Maryland State Retirement & Pension System first reported a position in DNA in Q2 2022 and held it in 7 quarters. The position peaked at $226K in Q2 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.
- Maryland State Retirement & Pension System reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
- Maryland State Retirement & Pension System sold 3,033 Ginkgo Bioworks shares in Q2 2024, an estimated $107K.
- Maryland State Retirement & Pension System first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 7 quarters.
- Maryland State Retirement & Pension System's Ginkgo Bioworks position peaked at $226K in Q2 2023.
- 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.
Based on Maryland State Retirement & Pension System's 13F filing for Q2 2024, filed 30 Jul 2024.